EMD
Click for more information
4.88% 4.3¢ emyria limited

An MDMA analogue which could end up in direct competition with...

  1. reon1
    1,388 Posts.
    lightbulb Created with Sketch. 443
    clock Created with Sketch.
    20/06/24
    09:01
    Post #: 74402338
    An MDMA analogue which could end up in direct competition with Emyria's own ones. Very strange.

    All to generate some professional fees. Emeryia has changed so much from a promising biotech to a clinical service provider.
    Last edited by reon1: 20/06/24
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
4.3¢ 		Change
0.002(4.88%) 		Mkt cap ! $16.76M
Open High Low Value Volume
4.2¢ 4.3¢ 4.1¢ $10.29K 244.7K

Buyers (Bids)

No. Vol. Price($)
1 26518 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 65258 1
View Market Depth
Last trade - 12.27pm 27/06/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.